NALIRIFOX as Induction Therapy in LAPC

Clinical trial NCT06467565 · UNKNOWN

Trial details

NCT number: NCT06467565
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma

Start date: 2023-12-25
Primary completion: 2024-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.